Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.48 CAD | -2.14% | +0.18% | -18.81% |
05-02 | Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% of its issued share capital. | CI |
05-02 | Quipt Home Medical Announces 10% Stock Buyback | MT |
Valuation
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 71 | 146.5 | 263.2 | 192.2 | 292.6 | 238.4 | - | - |
Enterprise Value (EV) 1 | 71 | 124.8 | 263.2 | 192.2 | 292.6 | 238.4 | 238.4 | 238.4 |
P/E ratio | -9.44 x | -18.7 x | -31.1 x | 32.2 x | -74.1 x | 157 x | 26.6 x | 8.82 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 0.88 x | 1.5 x | 2.02 x | 1.01 x | 0.98 x | 0.66 x | 0.61 x | 0.5 x |
EV / Revenue | 0.88 x | 1.5 x | 2.02 x | 1.01 x | 0.98 x | 0.66 x | 0.61 x | 0.5 x |
EV / EBITDA | 4.8 x | 7.04 x | 9.69 x | 4.84 x | 4.31 x | 2.86 x | 2.61 x | 2.24 x |
EV / FCF | - | 8.37 x | 15.2 x | 8.23 x | 6.47 x | 3.92 x | - | - |
FCF Yield | - | 11.9% | 6.59% | 12.1% | 15.5% | 25.5% | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 20,882 | 27,961 | 33,236 | 33,720 | 42,102 | 42,572 | - | - |
Reference price 2 | 3.400 | 5.240 | 7.920 | 5.700 | 6.950 | 5.480 | 5.480 | 5.480 |
Announcement Date | 20-01-28 | 21-02-01 | 22-01-27 | 22-12-21 | 23-12-18 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 80.97 | 97.76 | 130.1 | 190.5 | 297.3 | 361.5 | 392.3 | 473.3 |
EBITDA 1 | 14.8 | 20.8 | 27.17 | 39.74 | 67.83 | 83.46 | 91.18 | 106.5 |
EBIT 1 | 0.832 | 0.885 | 4.558 | 8.359 | 13.94 | 12.61 | 18.57 | 59.03 |
Operating Margin | 1.03% | 0.91% | 3.5% | 4.39% | 4.69% | 3.49% | 4.73% | 12.47% |
Earnings before Tax (EBT) 1 | -8.872 | -5.425 | -11.86 | 3.013 | -3.589 | 2.318 | 9.651 | 48.77 |
Net income 1 | -7.386 | -6.755 | -7.85 | 6.592 | -3.732 | 0.6274 | 9.174 | 24.3 |
Net margin | -9.12% | -6.91% | -6.03% | 3.46% | -1.26% | 0.17% | 2.34% | 5.13% |
EPS 2 | -0.3600 | -0.2800 | -0.2543 | 0.1771 | -0.0938 | 0.0349 | 0.2060 | 0.6215 |
Free Cash Flow 1 | - | 17.51 | 17.35 | 23.35 | 45.24 | 60.79 | - | - |
FCF margin | - | 17.91% | 13.33% | 12.25% | 15.22% | 16.82% | - | - |
FCF Conversion (EBITDA) | - | 84.17% | 63.85% | 58.74% | 66.7% | 72.83% | - | - |
FCF Conversion (Net income) | - | - | - | 354.16% | - | 9,688.1% | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 20-01-28 | 21-02-01 | 22-01-27 | 22-12-21 | 23-12-18 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: September | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 37.02 | 37.61 | 43.37 | 47.33 | 54.61 | 54.49 | 78.45 | 81.18 | 83.82 | 88.6 | 88.57 | 90.37 | 92.51 | 95.09 | 94.08 |
EBITDA 1 | 6.956 | 7.65 | 9.097 | 9.93 | 11.44 | 12.01 | 17.68 | 18.71 | 19.71 | 20.79 | 20.69 | 21.28 | 21.72 | 22.13 | 22.26 |
EBIT 1 | 0.0941 | 1.264 | 2.05 | 3.012 | 1.628 | 2.94 | 4.747 | 2.962 | 3.486 | 4.058 | 2.91 | 3.287 | 3.829 | 4.16 | 4.296 |
Operating Margin | 0.25% | 3.36% | 4.73% | 6.36% | 2.98% | 5.4% | 6.05% | 3.65% | 4.16% | 4.58% | 3.29% | 3.64% | 4.14% | 4.38% | 4.57% |
Earnings before Tax (EBT) 1 | -3.447 | -2.526 | 6.701 | 0.4102 | -0.8064 | 0.8785 | -1.011 | -1.827 | -1.661 | -0.4961 | 0.4566 | 0.8855 | 1.438 | 1.864 | 2.134 |
Net income 1 | -1.903 | -2.715 | 6.501 | 0.2103 | 2.411 | 0.4339 | -1.011 | -1.346 | -1.778 | -0.7943 | 0.435 | 0.8355 | 1.354 | 1.864 | 2.134 |
Net margin | -5.14% | -7.22% | 14.99% | 0.44% | 4.41% | 0.8% | -1.29% | -1.66% | -2.12% | -0.9% | 0.49% | 0.92% | 1.46% | 1.96% | 2.27% |
EPS 2 | -0.0509 | -0.0764 | 0.1807 | - | 0.0681 | 0.0134 | -0.0270 | -0.0404 | -0.0402 | -0.0136 | 0.009000 | 0.0246 | 0.0380 | 0.0475 | 0.0545 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-01-27 | 22-02-14 | 22-05-16 | 22-08-15 | 22-12-21 | 23-02-13 | 23-05-15 | 23-08-14 | 23-12-18 | 24-02-14 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | 21.7 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | 17.5 | 17.3 | 23.3 | 45.2 | 60.8 | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | -6.84% | - | - | - | - | - |
Assets 1 | - | - | 114.8 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | 0.5400 | - | - | - | - | - | - | - |
Capex | 1.8 | 0.12 | 6.42 | - | - | - | - | - |
Capex / Sales | 2.23% | 0.13% | 4.93% | - | - | - | - | - |
Announcement Date | 20-01-28 | 21-02-01 | 22-01-27 | 22-12-21 | 23-12-18 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 174M | |
+18.92% | 81.04B | |
-29.48% | 68.93B | |
+9.65% | 29.59B | |
-0.14% | 17.24B | |
-9.30% | 16.99B | |
+0.20% | 15.12B | |
+5.25% | 13.09B | |
+68.96% | 12B | |
-2.88% | 11.94B |
- Stock Market
- Equities
- QIPT Stock
- Financials Quipt Home Medical Corp.